EMEA-002115-PIP01-17-M01

Key facts

Active substance
Pretomanid
Therapeutic area
Infectious diseases
Decision number
P/0337/2019
PIP number
EMEA-002115-PIP01-17-M01
Pharmaceutical form(s)
  • Dispersible tablet
  • Tablet
Condition(s) / indication(s)
Treatment of multi-drug-resistant tuberculosis
Route(s) of administration
Oral use
Contact for public enquiries
Global Alliance for TB Drug Development

Tel. +1 2122277450
E-mail: info@tballiance.org

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating